Loading clinical trials...
Loading clinical trials...
An Evaluation of the Efficacy and Safety of Tapentadol Oral Solution in the Treatment of Post-operative Acute Pain Requiring Opioid Treatment in Pediatric Subjects Aged From Birth to Less Than 18 Years Old
Conditions
Interventions
Tapentadol oral solution 4 mg/mL
Tapentadol oral solution 20 mg/mL
+1 more
Locations
43
United States
US008
Little Rock, Arkansas, United States
US004
Stanford, California, United States
US011
Miami, Florida, United States
US012
Louisville, Kentucky, United States
US001
The Bronx, New York, United States
US018
The Bronx, New York, United States
Start Date
February 19, 2015
Primary Completion Date
March 3, 2019
Completion Date
March 14, 2019
Last Updated
January 18, 2020
NCT07422272
NCT07310953
NCT06184126
NCT06471075
NCT06569953
NCT06853041
Lead Sponsor
Grünenthal GmbH
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions